Evidence map›Paper›PMID 37792627›Full record

SynthesisThe journals of gerontology. Series A, Biological sciences and medical sciences2024

Beneficial Effect of Societal Factors on APOE-ε2 and ε4 Carriers' Brain Health: A Systematic Review.

José M Aravena, Jakyung Lee, Anna E Schwartz, Kate Nyhan, Shi-Yi Wang, Becca R Levy

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in The journals of gerontology. Series A, Biological sciences and medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. APOE genotype and cognitive decline: educational context as a moderator of genetic risk.The journals of gerontology. Series B, Psychological sciences and social sciences · 2025
    Article
  5. Review
  6. Observational
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

José M AravenaDepartment of Social & Behavioral Sciences, School of Public Health, Yale University, New Haven, Connecticut, USA.ORCID 0000-0002-5844-8700
Jakyung LeeInstitute for Community Care and Health Equity, Chung-Ang University, Seoul, Republic of South Korea.
Anna E SchwartzDepartment of Social & Behavioral Sciences, School of Public Health, Yale University, New Haven, Connecticut, USA.
Kate NyhanCushing/Whitney Medical Library, Department of Environmental Health Sciences, School of Public Health, Yale University, New Haven, Connecticut, USA.
Shi-Yi WangDepartment of Chronic Disease Epidemiology, School of Public Health, Yale University, New Haven, Connecticut, USA.ORCID 0000-0002-3294-5784
Becca R LevyDepartment of Social & Behavioral Sciences, School of Public Health, Yale University, New Haven, Connecticut, USA.ORCID 0000-0002-1611-7460
Yale University · USChung-Ang University · KRWhitney Museum of American Art · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Cognitive Resilience among Older SamoansR01AG067533 · NIA · YALE UNIVERSITY · PI LEVY, BECCA R · 2021 to 2025
$4.8M
Culture-Gene Relationship: A Novel Model of Aging Cognitive HealthU01AG032284 · NIA · YALE UNIVERSITY · PI LEVY, BECCA R · 2017 to 2020
$1.7M
NCATS NIH HHS UL1 TR001863NIA NIH HHS R01 AG067533NIA NIH HHS R01AG067533NIA NIH HHS U01 AG032284
6 · The paper itself

Abstract

backgroundApolipoprotein-E (APOE) ε4 and ε2 are the most prevalent risk-increasing and risk-reducing genetic predictors of Alzheimer's disease, respectively. However, the extent to which societal factors can reduce the harmful impact of APOE-ε4 and enhance the beneficial impact of APOE-ε2 on brain health has not yet been examined systematically.

methodsTo fill this gap, we conducted a systematic review searching for studies in MEDLINE, Embase, PsycINFO, and Scopus until June 2023, that included: (a) 1 of 5 social determinants of health (SDH) identified by Healthy People 2030, (b) APOE-ε2 or APOE-ε4 allele carriers, (c) cognitive or brain-biomarker outcomes, and (d) studies with an analysis of how APOE-ε2 and/ or APOE-ε4 carriers differ on outcomes when exposed to SDH.

resultsFrom 14 076 articles retrieved, 124 met the inclusion criteria. In most of the studies, exposure to favorable SDH reduced APOE-ε4's detrimental effect and enhanced APOE-ε2's beneficial effect on cognitive and brain-biomarker outcomes (cognition: 70.5%, n: 74/105; brain-biomarkers: 71.4%, n: 20/28). A similar pattern of results emerged in each of the 5 Healthy People 2030 SDH categories, where finishing high school, having resources to satisfy basic needs, less air pollution, less negative external stimuli that can generate stress (eg, negative age stereotypes), and exposure to multiple favorable SDH were associated with better cognitive and brain health among APOE-ε4 and APOE-ε2 carriers.

conclusionsSocietal factors can reduce the harmful impact of APOE-ε4 and enhance the beneficial impact of APOE-ε2 on cognitive outcomes. This suggests that plans to reduce dementia should include community-level policies promoting favorable SDH.

Indexed as

Alzheimer DiseaseApolipoproteins EAllelesApolipoprotein E2Apolipoprotein E4BiomarkersBrainGenotypeHumansApoE protein, humanApolipoprotein E2Apolipoprotein E4Apolipoproteins EBiomarkersApolipoprotein E4Cognitive impairmentCognitive reserveHealth disparityMinority and vulnerable populations

Identifiers

PMID37792627
PMCPMC10803122
OpenAlexW4387327492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.